Ignite Creation Date:
2025-12-24 @ 5:33 PM
Ignite Modification Date:
2026-02-18 @ 9:30 PM
Study NCT ID:
NCT00211068
Status:
COMPLETED
Last Update Posted:
2013-04-30
First Post:
2005-09-13
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study of Risk Factors for Anti-erythropoietin Antibody Positive Pure Red Cell Aplasia Among Patients With Chronic Kidney Disease Receiving Epoetin Alfa
Sponsor:
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Pure Red-cell Aplasia | View |